Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Liquidia Corporation. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Liquidia Corporation (LQDA) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Liquidia Corporation (“Liquidia” or “the Company”) (NASDAQ: LQDA). Investors who purchased Liquidia securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Liquidia has violated federal securities laws.
What Potential Securities Violations Is BG&G Investigating?
On October 5, 2026, Liquidia Corporation announced an adverse ruling in United Therapeutics’ patent litigation concerning Yutrepia. The court found two of six asserted claims of the ’327 patent valid and infringed, raising the possibility of an injunction, restrictions on Yutrepia’s availability, and potential removal of its PH-ILD indication. Previously, in its August 12, 2026 Form 10-Q, Liquidia stated that its pending litigation matters represented “none of which do we believe represent a risk of material loss or exposure.” Following this news, Liquidia’s stock price fell approximately 57%.
What Should Liquidia Corporation (LQDA) Investors Do?
If you are aware of any facts relating to this investigation or purchased Liquidia securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
How Is Liquidia Corporation (NASDAQ: LQDA) Stock Trading Today?
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”